Prolactin-secreting adenomas. Surgical results;LES ADENOMES HYPOPHYSAIRES SECRETANT DE LA PROLACTINE. LES RESULTATS DE LEUR TRAITEMENT CHIRURGICAL

Neurochirurgie

Volumn 42, Issue 1, 1996, Pages 44-53

  Otten, Ph ^a   Rilliet, B ^a   Reverdin, A ^a   Demierre, B ^a   Berney, J ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Hyperprolactinemia; Prolactinomas; Transphenoidal microsurgery

Indexed keywords

PROLACTIN;

ADULT; AMENORRHEA; ARTICLE; CANCER SURGERY; FEMALE; FOLLOW UP; HUMAN; HYPOPHYSIS ADENOMA; IMPOTENCE; MAJOR CLINICAL STUDY; MALE; MICROSURGERY; PROLACTIN BLOOD LEVEL; RETROSPECTIVE STUDY; TRANSSPHENOIDAL SURGERY; TUMOR RECURRENCE; TUMOR VOLUME; BLOOD; DECISION TREE; HYPOPHYSIS TUMOR; PROLACTINOMA; SECRETION; TREATMENT OUTCOME;

ADULT; DECISION TREES; FEMALE; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; PITUITARY NEOPLASMS; PROLACTIN; PROLACTINOMA; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0029978978     PISSN: 00283770     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. ADAMS CBT, BURKE CW. Current modes of treatment of pituitary tumours. Br J Neurosurg 1993 ; 7 : 123-8.
2. BARROW DL, TIXDALL GT, KOVACS K, THORNER MO, HORVATH E, HOFFMANN JC. Clinical and pathological effects of bromocriptine on prolactin-secreting and other pituitary tumors. J Neurosurg 1984 ; 60 : 1-7.
3. BARROW DL, MEZUNO J, TINDALL GT. Management of prolactinomas associated with very high serum prolactin levels. J Neurosurg 1988 ; 68 : 554-8.
4. BERGSTROM M, MUHR C, LUNDBERG PO, LAXGSTROM B. PET as a tool in the clinical evaluation of pituitary adenomas. J Nucl Med 1991 ; 32 : 610-5.
5. BEVAN JS, ADAMS CBT, BURKE CW et al. Factors in the outcome of transsphenoidal surgery for prolactinoma and non-fuctionning pituitary tumour, including pre-operative bromocriptine therapy. Clin Endocrinol 1987 ; 26 : 541-56.
6. BILLER BM, BAUM HB, ROSENTHAL DL. SAXE VC, CHARPIE PM, KLIBANSKI A. Progressive trabecular osteopenia in women with hyperprolactinemic amenorrhea. J Clin Endocrinol Metab 1992 ; 75 : 690-1.
7. CICCARELLI E, GHIGO E, MIOLA C, GANDINI G. MULLER EE, CAMANNI F. Long-term follow-up of « cured » prolactinomas patients after successful adenectomy. Clin Endocrinol 1990 ; 32 : 583-92.
8. CROTTAZ B, USKE A, REYMOND MJ et al. CV 205-502 treatment of macroprolactinomas. J Endocrinol Invest 1991 ; 14 : 757-62.
9. CUNNAH D, BESSER M. Managements of prolactinomas. Clin Endocrinol 1991 ; 34 : 231-5.
10. 18F-fluoro-deoxyglucose in prolactinomas in relation to bromocriptine treatment. Eur J Nucl Med 1991 ; 18 : 453-60.
11. FAGLIA G. Should dopamine agonist treatment for prolactinoma be life-long ? Clin Endocrinol 1991 ; 34 : 173-4.
12. FOSSATI P, DEWAILLY D, THOMAS-DESROUSSEAUX P et al. Medical treatment of hyperprolactinemia. Horm Res 1985 ; 22 : 228-38.
13. FRANCAVILLA TL, MILETICH RS, DEMICHELE D et al. Positron emission tomography of pituitary macroademomas : hormone production and effects of therapy. Neurosurgery 1991 ; 28 : 826-33.
14. GASSER RW, MUELLER-HOLZNER E, SKRABAL F et al. Macroprolactinomas and functionless pituitary tumors. Immunostaining and effect of dopamine agonist therapy. Acm Endocrinol (Copenh) 1987 ; 776 : 253-9.
15. GEM M, UOZOMI T, OHTA M, ITO A, KAJIWARA H, MORI S. Necrotic changes in prolactinomas after long term administration of bromocriptine. J Clin Endocrinol Metab 1984 ; 59 : 463-70.
16. GORDON D, RICHARDS A, BULLOCH R et al. Prolactin dynamics and tumor size in the prediction of surgical outcome for prolactinoma. Q J Med 1985 ; 214 : 141-51.
17. GRIGSBY PW, SIMPSON JR, FINEBERG B. Late regrowth of pituitary adenomas after irradiation and/or surgery. Cancer 1989 ; 63 : 1308-12.
18. GRISOU F, BRUE TH, GRAZIANI N et al. Enlarged adenectomy for enclosed prolactinomas : a preliminary study of 26 cases. Acta Neurochir (Wien) 1990 ; 103 : 92-8.
19. KLIBANSKI A, ZERVAS NT. Diagnosis and management of hormone-secreting pituitary adenomas. N Engl J Med 1991 ; 324 : 822-31.
20. HYPERPROLACTINAEMIA : When is a prolactinoma not a prolactinoma ? (Editorial) Lancet 1987 ; 2 (8566) : 1002-4.
21. LANCRANJAN I. The medical treatment of prolactin and growth hormone secreting pituitary tumors. Acta Neurochir (suppl) 1990 ; 47 : 71-85.
22. LANDOLT AM. OSTERW ALDER V. Perivascular fibrosis in prolactinomas : Is it increased by bromocriptine ? J Clin Endocrinol Melab 1984 ; 58 : 1179-83.
23. LESSER RL, ZHEUTLIN ID, BOGHEN D, ODEL JG, ROBBIKS RJ. Visual function improvement in patients with macroprolactinomas treated with bromocriptine. Am J Ophtalmol 1990 ; 109 : 535-43.
24. LITTLEY MD, SHALET SM, REID H, BEARDWELL CG, SUTTON ML. The effect of external pituitary irradiation on elevated serum prolactin levels in patients with pituitary macroadenomas. Q J Med 1991 ; 296 : 985-98.
25. MAIRA G, ANILE G, DE MARINIS L, BARBARINO A. Prolactin-secreting adenomas : surgical results and long-term follow-up. Neurosurgery 1989 ; 24 : 736-43.
26. MARASCHINI C, MORO M, MASALA A. Chronic treatment with Parlodel LAR of patients with prolactin-secreting tumors. Different responsiveness of micro- and macroprolactinomas. Acta Endocrinol (Copenh) 1991 ; 725 : 494-501.
27. MBANFYA JC, MENDELOW AD, CRAWFORD PJ, HALL K. DEWAR JH, KENDALL-TAYLOR P. Rapid resolution of visual abnormalities with medical therapy alone in patients with large prolactinomas. Er J Neurosurg 1993 ; 7 : 519-27.
28. MOBERG E, AF TRAMPE E. WERSÄLL J, WERNER S. Longterm effects of radiotherapy and bromocriptine treatment in patients with previous surgery for macroprolactinomas. Neurosurgery 1991 ; 29 : 200-5.
29. MOLITCH ME. Management of prolactinomas. Ann Rev Med 1989 ; 40 : 225-32.
30. MUHR C, BERGSTROM M. Positron emission tomography applied in the study of pituitary adenomas. J Endocrinol Invest 1991 ; 14 : 509-28.
31. NADALON S. DE BUHAN B, ARCHAMBEAUD-MOUVEROUX F, FOURNIER MP. HUC MC, LAUBIE B. Traitement des adénomes à prolactine. Rev Med Int 1990 ; 11 : 172-80.
32. PERRIN G, TRELUYER C, TROUILLAS J, SASSOLAS G. GOUTELLE A. Surgical outcome and pathological effects of bromocriptine preoperative treatment in prolactinomas. Path Res Lab Med 1991 ; 187 : 587-92.
33. RANDALL RV, BERND W, SCHEITHAUER BW et al. Pituitary adenomas associated with hyperprolactinemia : a clinical and irnmunohistochemical study of 97 patients operated on transsphenoidally. Mayo Clin Proc 1985 ; 60 : 753-62.
34. REINLIE S, HAAKONSEN M, ELDEVIK OP, NESBAKKEN R. Volumes of pituitary adenomas related to hormone production, duration of symptoms and postoperative outcome. Acta Radiol Suppl (Stockh) 1986 ; 369 : 306-9.
35. RODMANN EF, MOLITCH ME. POST KD, BILLER BJ. REICHLIN S. Long-term follow-up of transsphenoidal selective adenectomy for prolactinoma. JAMA 1984 ; 252 : 921-4.
36. RUSH SC, NEW ALL J. Pituitary adenoma : the efficacy of radiotherapy as the sole treatment. Int J Radiat Oncol Biol Phys 1989 ; 77 : 165-9.
37. SAITOH Y, MORI S, ARITA N et al. Treatment of prolactinoma based on the results of transsphenoidal operations Surg Neural 1986 ; 26 : 338-44.
38. SAMAAN NA, SCHULTZ PN, LEAVENS TA, LEAVENS ME, LEE YY. Pregnancy after treatment in patients with prolactinoma : operation versus bromocriptine. Am J Obstet Gynecol 1986 ; 755 : 1300-5.
39. SCAMONI C, BALZARINI C, CRIVELLI G, DORIZZI A. Treatment and long-term follow-up results of prolactin secreting pituitary adenoma. J Neurosurg Sci 1991 ; 35: 9-16.
40. SCANLON MF, PETERS JR, SALVADOR J et al. The preoperative and postoperative investigation of TSH and prolactin release in the management of patients with hyperprolactinaemia due to prolactinomas and non functional pituitary tumours : relationship to adenoma size at surgery. Clin Endocrinol 1986 ; 24 : 435-46.
41. SCHLECHTE J, WALKNER L, KATHOL M. A longitudinal analysis of premenopausal bone loss in healthy women and woman with hyperprolactinemia. J Clin Endocrinol Metab 1992 ; 74 : 698-703.
42. SERRI O, RASIO E, BEAUREGARD H, HARDY J, SOMMA M. Recurrence of hyperprolactinemia after selective transsphenoidal adenectomy in woman with prolactinoma. N Engl J Med 1983 ; 309 : 280-3.
43. SERRI O, HARDY J, MASSOUD F. Relapse of hyperprolactinemia revisited. N Engl J Med 1993 ; 329 : 1357.
44. THOMSON JA, TEASDALE GM, GORDON D, MCCRUDEN DC, DAVIES DL. Treatment of presumed prolactinoma by transsphenoidal operation : early and late results. Br Med J 1985 ; 29 : 1550-3.
45. TINDALL GT, WOODARD EJ. Prolactinomas : diagnosis and management. Comemp Neurosurg 1990 ; 12 : 1-6.
46. TSAGARAKJS S, GROSSMAN A. PLOWMANN PN et al. Megavoltage pituitary irradiation in the management of prolactinomas : long-term follow-up. Clin Endocrinol 1991 ;34 : 399-406.
47. VAN'T VERLAAT JW, CROUGHS RJM. Withdrawal of bromocriptine after long-term therapy for macroprolactinomas ; effect on plasma prolactin and tumour size. Clin Endocrinol 1991 ; 34 : 175-8.
48. VERTOSICK FT. Role of defective dopaminergic inhibition of prolactin secretion in the pathogenesis of prolactinoma. Neurosurgery 1985 ; 16 : 261-6.
49. VEZINA JL. MALTAIS R. La selle turcique dans I'acromégalie. Etude radiologique. Neurochirurgie (suppl) 1973 ; 19 : 35-56.
50. WEBSTER J, PAGE MD, BEVAN JS, RICHARDS SH, DOUGLAS-JONES AG, SCANLON MF. Low recurrence rate after partial hypophysectomy for prolactinoma : th predictive value of dynamic prolactin function tests. Clin Endocrinol 1992 ; 36 : 35-44.
51. ZARATE A, CANALES ES, CANO C, PILONIETA CJ. Followup of patients with prolactinomas after discontinuation of long-term therapy with bromocriptine. Ada Endocrinol 1983 ; 104 : 139-42.